BodyCap, a company based in Caen, France, won the European CE Mark to introduce its e-Celsius swallowable wireless thermometer. Designed to monitor patients’ core temperature, the e-Celsius looks like and is ingested just like a regular drug capsule. As it moves down the GI tract, every 30 seconds the device wirelessly transmits data to an “e-Viewer” that displays the readings and records the temperature during the pill’s journey.
During studies, the e-Celsius demonstrated consistency of measurements and the fact that the GI tract has a generally uniform temperature throughout. The readings have matched those taken rectally, while avoiding having to access regions untainted by the sun. Once the pill makes its way through the GI tract, it is simply expelled along with everything else down there.
The e-Viewer can be pre-programmed to issue warnings if the temperature moves outside of a set range. This can be important in fragile patients, including those with a compromised immune system that are at risk of infection. The device can also benefit clinicians watching over patients during lengthy surgeries, as well as during recovery.
Each pill will cost between €40 and €60 ($42 and $63) and comes with an activation box that’s used to engage the e-Celsius and partner it with a particular e-Viewer.
Here are some of the features of the electronic pill and e-Viewer:
- Storage: Up to one year
- Weight: 1.7g
- Size: 17.7mm x 8.9 mm
- Sampling: 30s
- Accuracy: 0.2°C
- Operational range: 25°C to 45°C
- Stores up to 2000 data
- Wireless transmission (433 MHz)
- Communication range: 1 m
- Operational duration: 20 days
e-Viewer:
- 3 pills per monitor
- Multichannel: 7 monitors in parallel
- Storage: 80 000 data per pill
- Autonomy in charge: 24h
- Size: 120mm x 70mm x 15mm
Product page: e-Celsius…
Via: BodyCap…
